Lance L. Simpson

6.5k total citations
134 papers, 4.6k citations indexed

About

Lance L. Simpson is a scholar working on Neurology, Cellular and Molecular Neuroscience and Molecular Biology. According to data from OpenAlex, Lance L. Simpson has authored 134 papers receiving a total of 4.6k indexed citations (citations by other indexed papers that have themselves been cited), including 94 papers in Neurology, 51 papers in Cellular and Molecular Neuroscience and 28 papers in Molecular Biology. Recurrent topics in Lance L. Simpson's work include Botulinum Toxin and Related Neurological Disorders (92 papers), Neurological disorders and treatments (56 papers) and Hereditary Neurological Disorders (27 papers). Lance L. Simpson is often cited by papers focused on Botulinum Toxin and Related Neurological Disorders (92 papers), Neurological disorders and treatments (56 papers) and Hereditary Neurological Disorders (27 papers). Lance L. Simpson collaborates with scholars based in United States, Canada and United Kingdom. Lance L. Simpson's co-authors include Andrew B. Maksymowych, Maurice M. Rapport, N Bakry, Julie A. Coffield, Bibhuti R. DasGupta, David Hoch, Fetweh H. Al‐Saleem, Robert V. Considine, Alexei V. Finkelstein and Barbara E. Ehrlich and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Journal of Neuroscience.

In The Last Decade

Lance L. Simpson

133 papers receiving 4.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lance L. Simpson United States 35 3.2k 1.8k 1.2k 615 493 134 4.6k
Shunji Kozaki Japan 38 2.2k 0.7× 1.8k 1.0× 1.8k 1.5× 610 1.0× 864 1.8× 158 5.2k
Raymond P. Roos United States 48 1.9k 0.6× 912 0.5× 2.1k 1.8× 624 1.0× 382 0.8× 170 6.6k
Bernard Poulain France 35 2.2k 0.7× 2.1k 1.2× 2.1k 1.8× 370 0.6× 1.3k 2.7× 91 4.9k
Edward J. Thompson United Kingdom 40 1.6k 0.5× 867 0.5× 1.6k 1.4× 599 1.0× 346 0.7× 145 5.0k
Bibhuti R. DasGupta United States 34 4.5k 1.4× 2.4k 1.3× 2.5k 2.1× 667 1.1× 1.7k 3.4× 124 6.4k
Juan Blasi Spain 34 1.9k 0.6× 1.9k 1.1× 2.6k 2.1× 318 0.5× 2.2k 4.5× 114 5.3k
Yasuhiro Yamamura United States 28 3.5k 1.1× 2.3k 1.3× 2.5k 2.1× 202 0.3× 681 1.4× 84 6.5k
Patricia J. Armati Australia 33 763 0.2× 830 0.5× 817 0.7× 428 0.7× 266 0.5× 81 4.0k
Dieter Müller Germany 30 977 0.3× 717 0.4× 972 0.8× 199 0.3× 118 0.2× 123 3.4k
Edward Mee New Zealand 33 1.1k 0.3× 803 0.4× 878 0.7× 434 0.7× 104 0.2× 93 3.6k

Countries citing papers authored by Lance L. Simpson

Since Specialization
Citations

This map shows the geographic impact of Lance L. Simpson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lance L. Simpson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lance L. Simpson more than expected).

Fields of papers citing papers by Lance L. Simpson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lance L. Simpson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lance L. Simpson. The network helps show where Lance L. Simpson may publish in the future.

Co-authorship network of co-authors of Lance L. Simpson

This figure shows the co-authorship network connecting the top 25 collaborators of Lance L. Simpson. A scholar is included among the top collaborators of Lance L. Simpson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lance L. Simpson. Lance L. Simpson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Jones, R. Mark, et al.. (2008). A Human Monoclonal Antibody that Binds Serotype A Botulinum Neurotoxin. Hybridoma. 27(1). 11–17. 17 indexed citations
3.
Al‐Saleem, Fetweh H., et al.. (2008). A Natural Human IgM Antibody that Neutralizes Botulinum Neurotoxin in vivo. Hybridoma. 27(2). 65–69. 8 indexed citations
4.
Al‐Saleem, Fetweh H., et al.. (2008). The Role of Systemic Handling in the Pathophysiologic Actions of Botulinum Toxin. Journal of Pharmacology and Experimental Therapeutics. 326(3). 856–863. 24 indexed citations
5.
Ahsan, Chowdhury Rafiqul, György Hajnóczky, Andrew B. Maksymowych, & Lance L. Simpson. (2005). Visualization of Binding and Transcytosis of Botulinum Toxin by Human Intestinal Epithelial Cells. Journal of Pharmacology and Experimental Therapeutics. 315(3). 1028–1035. 46 indexed citations
6.
Simpson, Lance L., et al.. (2003). Immunologic Characterization of Spasmodic Dysphonia Patients Who Develop Resistance to Botulinum Toxin. Journal of Voice. 17(2). 255–264. 23 indexed citations
7.
Simpson, Lance L.. (1999). Botulinum Toxin: Potent Poison, Potent Medicine. Hospital Practice. 34(4). 87–91. 13 indexed citations
8.
Viera, G., et al.. (1993). Lessons learned from the ethylene oxide explosion at Seadrift, Texas. Chemical engineering progress. 89(8). 66–75. 14 indexed citations
9.
Simpson, Lance L., Gregory T. Lautenslager, Ivan I. Kaiser, & John L. Middlebrook. (1993). Identification of the site at which phospholipase A2 neurotoxins localize to produce their neuromuscular blocking effects. Toxicon. 31(1). 13–26. 40 indexed citations
10.
Bakry, N, et al.. (1991). Lectins from Triticum vulgaris and Limax flavus are universal antagonists of botulinum neurotoxin and tetanus toxin.. Journal of Pharmacology and Experimental Therapeutics. 258(3). 830–836. 48 indexed citations
11.
Simpson, Lance L., et al.. (1988). Partial characterization of the enzymatic activity associated with the binary toxin (type C2) produced by Clostridium botulinum. Infection and Immunity. 56(1). 24–27. 9 indexed citations
12.
Simpson, Lance L.. (1984). Fragment C of tetanus toxin antagonizes the neuromuscular blocking properties of native tetanus toxin.. Journal of Pharmacology and Experimental Therapeutics. 228(3). 600–604. 23 indexed citations
13.
Simpson, Lance L. & Bibhuti R. DasGupta. (1983). Botulinum neurotoxin type E: studies on mechanism of action and on structure-activity relationships.. Journal of Pharmacology and Experimental Therapeutics. 224(1). 135–140. 43 indexed citations
14.
Simpson, Lance L.. (1983). Ammonium chloride and methylamine hydrochloride antagonize clostridial neurotoxins.. Journal of Pharmacology and Experimental Therapeutics. 225(3). 546–552. 69 indexed citations
15.
Simpson, Lance L.. (1981). The origin, structure, and pharmacological activity of botulinum toxin.. Pharmacological Reviews. 33(3). 155–188. 177 indexed citations
16.
Simpson, Lance L.. (1980). Evidence that there are subcellular pools of norepinephrine and that there is flux of norepinephrine between these pools.. Journal of Pharmacology and Experimental Therapeutics. 214(2). 410–416. 2 indexed citations
17.
Simpson, Lance L.. (1976). Drug Treatment of Mental Disorders. Raven Press eBooks. 6 indexed citations
18.
Simpson, Lance L., et al.. (1976). The role of acetylcholine receptors and acetylcholinesterase activity in the development of denervation supersensitivity.. Journal of Pharmacology and Experimental Therapeutics. 198(3). 507–517. 23 indexed citations
19.
Simpson, Lance L. & E. B. Adams. (1971). Poisons of animal origin. Plenum Press eBooks. 1 indexed citations
20.
Simpson, Lance L. & Jack T. Tapp. (1967). Actions of calcium and magnesium on the rate of onset of botulinum toxin paralysis of the rat diaphragm. International Journal of Neuropharmacology. 6(6). 485–492. 29 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Shunji Kozaki Breakdown of academic impact, for papers by Raymond P. Roos Breakdown of academic impact, for papers by Bernard Poulain Breakdown of academic impact, for papers by Edward J. Thompson Breakdown of academic impact, for papers by Bibhuti R. DasGupta Breakdown of academic impact, for papers by Juan Blasi Breakdown of academic impact, for papers by Yasuhiro Yamamura Breakdown of academic impact, for papers by Patricia J. Armati Breakdown of academic impact, for papers by Dieter Müller Breakdown of academic impact, for papers by Edward Mee
Rankless by CCL
2026